(Q43706125)

26 November 2017

title

Oral transmucosal fentanyl and sufentanil for incident pain (English)

1 reference

26 November 2017

0 references

Gardner-Nix J

1

1 reference

26 November 2017

publication date

1 August 2001

1 reference

Journal of Pain and Symptom Management

26 November 2017

published in

1 reference

26 November 2017

volume

22

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

627-630

1 reference

Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900321-9

7 January 2021

Sublingual absorption of selected opioid analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900321-9

7 January 2021

Transdermal fentanyl for pain control in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900321-9

7 January 2021

Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900321-9

7 January 2021

Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900321-9

7 January 2021

Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2801%2900321-9

7 January 2021

10.1016/S0885-3924(01)00321-9

Identifiers

DOI

1 reference

26 November 2017

1 reference